Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry
Status: | Completed |
---|---|
Conditions: | Irritable Bowel Syndrome (IBS), Gastrointestinal |
Therapuetic Areas: | Gastroenterology |
Healthy: | No |
Age Range: | Any - 16 |
Updated: | 2/20/2019 |
Start Date: | January 28, 2002 |
End Date: | June 1, 2014 |
The purpose of the Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry
is to study the contemporary natural history of children <16 years of age newly diagnosed
with inflammatory bowel disease. The project follows these children quarterly from diagnosis
examining clinical, laboratory, and humanistic outcomes. Genetic and serologic monitoring is
performed on the study population.
is to study the contemporary natural history of children <16 years of age newly diagnosed
with inflammatory bowel disease. The project follows these children quarterly from diagnosis
examining clinical, laboratory, and humanistic outcomes. Genetic and serologic monitoring is
performed on the study population.
Observations of children with IBD often suggest a more severe course than that found in
adults. Explanations for this are unclear, especially since children are less likely to
engage in some behaviors (e.g., smoking) that may have a deleterious effect on disease course
as noted in adults. In many ways children are a better "experimental model" of IBD because
they don't have as many confounding medical factors as adults. Both Crohn's disease and
ulcerative colitis are believed to result from a complex interaction of genetic and
environmental factors (1). Recently, the gene CARD15/NOD2 on chromosome 16 has been
identified in approximately 25% of Caucasian patients with Crohn's disease and is felt to be
a significant predisposing factor to the development of fibrostenosing disease (2).
Additionally, seropositivity for perinuclear antinuclear cytoplasmic factor (pANCA) has been
demonstrated much more frequently in patients with ulcerative colitis than in those with
Crohn's disease, while anti-Saccharomyces antibody (ASCA) is more common in the latter
population (3). The importance of these serological abnormalities is not clear, though some
data suggest an influence on the development of complications.
Our hypothesis is that phenotypic, genotypic and serologic characteristics may provide
prognostic information on response to therapy and course in children with IBD. This type of
prognostic information is particularly important as newer therapies are developed.
adults. Explanations for this are unclear, especially since children are less likely to
engage in some behaviors (e.g., smoking) that may have a deleterious effect on disease course
as noted in adults. In many ways children are a better "experimental model" of IBD because
they don't have as many confounding medical factors as adults. Both Crohn's disease and
ulcerative colitis are believed to result from a complex interaction of genetic and
environmental factors (1). Recently, the gene CARD15/NOD2 on chromosome 16 has been
identified in approximately 25% of Caucasian patients with Crohn's disease and is felt to be
a significant predisposing factor to the development of fibrostenosing disease (2).
Additionally, seropositivity for perinuclear antinuclear cytoplasmic factor (pANCA) has been
demonstrated much more frequently in patients with ulcerative colitis than in those with
Crohn's disease, while anti-Saccharomyces antibody (ASCA) is more common in the latter
population (3). The importance of these serological abnormalities is not clear, though some
data suggest an influence on the development of complications.
Our hypothesis is that phenotypic, genotypic and serologic characteristics may provide
prognostic information on response to therapy and course in children with IBD. This type of
prognostic information is particularly important as newer therapies are developed.
Inclusion Criteria:
1. Definite diagnosis of ulcerative colitis, Crohn's disease, indeterminate colitis
2. Age up to 16 years and zero days at time of diagnosis
3. Informed consent/assent from parent/guardian and patient
4. Ability to be available for regular follow-up visits
Exclusion Criteria:
1. Diagnosis of IBD greater than 1 month prior to presentation to participating center
2. Age greater than 16 years and zero days
3. Inability to be available for regular follow-up visits
We found this trial at
25
sites
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
Click here to add this to my saved trials
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
Click here to add this to my saved trials
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
1-513-636-4200
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
Click here to add this to my saved trials
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
Click here to add this to my saved trials
Connecticut Children's Medical Center Connecticut Children’s Medical Center is a nationally recognized, 187-bed not-for-profit children’s...
Click here to add this to my saved trials
Click here to add this to my saved trials
Nemours Children's Clinic At Nemours Children’s Clinic, Jacksonville, we've treated every child as we would...
Click here to add this to my saved trials
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
Click here to add this to my saved trials
Rhode Island Hospital Founded in 1863, Rhode Island Hospital in Providence, RI, is a private,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Cleveland Clinic Foundation The Cleveland Clinic (formally known as The Cleveland Clinic Foundation) is a...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Morristown Memorial Hospital Atlantic Health System – comprised of Morristown Medical Center, Overlook Medical Center,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials